Article
Identification of two missense mutations in a dihydrolipoamide dehydrogenase-deficient patient.
Proceedings of the National Academy of Sciences of the United States of America - 1 Jun 1993
Liu T C, Kim H, Arizmendi C, Kitano A, Patel M S
Abstract excerpt
The molecular basis of dihydrolipoamide dehydrogenase (E3; dihydrolipoamide:NAD+ oxidoreductase, EC 1.8.1.4) deficiency in an E3-deficient patient was studied. Fibroblasts cultured from the patient contained only approximately 6% of the E3 activity of cells from a normal subject. Western and Northern blot analyses indicated that, compared to control cells, the patient's cells had a reduced amount of protein but...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
